Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
RESEARCH TOOLSreports
Pasithea Therapeutics Corp (KTTA) Stock Price & Analysis
27 Followers
KTTA Stock Chart & Stats
Day’s Range$7.24 - $7.24
52-Week Range― - ―
Previous Close$6.95
Volume331.00
Average Volume (3M)N/A
Market Cap
$7.39M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Mar 30, 2022EPS Estimate
-$1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pasithea Therapeutics Corp News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KTTA FAQ
What was Pasithea Therapeutics Corp’s price range in the past 12 months?
Currently, no data Available
What is Pasithea Therapeutics Corp’s market cap?
Currently, no data Available
When is Pasithea Therapeutics Corp’s upcoming earnings report date?
Pasithea Therapeutics Corp’s upcoming earnings report date is Mar 30, 2022 which is 759 days ago.
How were Pasithea Therapeutics Corp’s earnings last quarter?
Currently, no data Available
Is Pasithea Therapeutics Corp overvalued?
According to Wall Street analysts Pasithea Therapeutics Corp’s price is currently Overvalued.
Does Pasithea Therapeutics Corp pay dividends?
Pasithea Therapeutics Corp does not currently pay dividends.
What is Pasithea Therapeutics Corp’s EPS estimate?
Pasithea Therapeutics Corp’s EPS estimate is -$1.
How many shares outstanding does Pasithea Therapeutics Corp have?
Currently, no data Available
What happened to Pasithea Therapeutics Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pasithea Therapeutics Corp?
Currently, no hedge funds are holding shares in KTTA
---
Pasithea Therapeutics Corp Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.3%
Last 30 Days ▼ 5.9%
Last 30 Days ▼ 5.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.05%
12-Months-Change
Fundamentals
Return on Equity
-47.07%
Trailing 12-Months
Asset Growth
-42.19%
Trailing 12-Months
Company Description
Pasithea Therapeutics Corp
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.
---
KTTA Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering KTTA
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-0.70%
initiated a buy rating 11 months ago
Copying Elemer Piros's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -0.70% per trade.
---